MedKoo Biosciences

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

 

 

 

 

 

 

 

Back to products

 

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

 


Other drug agents

Drug intermediates

Bio-reagents and biochemicals

 

 

   

 

 

 

 

MedKoo product information:

 

Golotimod

  

Description of Golotimod: Golotimod is an orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and antineoplastic activities. Although the exact mechanism of action is unknown, golotimod appears to inhibit the expression of STAT-3, reversing immunosuppression and stimulating an anti-tumor immune response. This agent may stimulate the production of T-lymphocytes (in particular the helper T [Th1] cells), activate macrophages, and increase levels of interleukin 2 and interferon gamma. STAT-3, a transcription factor upregulated in many cancer cell types, is involved in tumor cell growth and survival and immunosuppression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

 

Current developer:   SciClone Pharmaceuticals

  

MedKoo Code#: 201442

Name: Golotimod

CAS#:  229305-39-9

 

Synonym:  SCV 07;  gamma-D-glutamyl-L-tryptophan.

  

IUPAC/Chemical name:

(R)-2-amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic acid

  

Chemical structure:

Theoretical analysis

  

  

  

Chemical Formula: C16H19N3O5

Exact Mass: 333.13247

Molecular Weight: 333.34

Elemental Analysis: C, 57.65; H, 5.75; N, 12.61; O, 24.00

  

  

Availability and price:

 

This product is available through custom synthesis.

  

To inquire the quotation and lead time of custom synthesis for this agent, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

 

Quality control data:

Product will be shipped with supporting analytical data.

 

 

Information about this agent

Golotimod (SCV-07) is currently developed by SciClone Pharmaceuticals. According to Sciclone's website, This agent appears to stimulate the immune system through inhibition of STAT3 signaling and the resulting effects on T-helper 1 cells. SCV-07 has been shown to be efficacious in animal models of immune-sensitive diseases, including OM prevention, treatment of viral infections and cancers, and in the enhancement of response to vaccines. SciClone has exclusive worldwide rights to SCV-07 outside of Russia, where the molecule has recently been approved for stimulation of depressed immune systems.

  

References

1. Sharma, Geeta; Altmeyer, Ralf; Pendharker, Vishal; Chen, Yu; Foley, Michael. Compositions and methods for treating viral infections. U.S. Pat. Appl. Publ. (2010), 38pp. CODEN: USXXCO US 2010081713 A1 20100401 CAN 152:422252 AN 2010:409307

2. Rios, Israel; Tuthill, Cynthia W. Treatment or prevention of hepatitis C with immunomodulator compounds. PCT Int. Appl. (2010), 20pp. CODEN: PIXXD2 WO 2010017178 A1 20100211 CAN 152:231192 AN 2010:179070

3. Hausman, Diana F.; Dodds, Michael G. Use of PEGylated type III interferons for the treatment of hepatitis C. PCT Int. Appl. (2009), 95pp. CODEN: PIXXD2 WO 2009149377 A1 20091210 CAN 152:55951 AN 2009:1536376

4. Tu, Chun-Yan; Wu, Yan-Jiao; Yuan, Yan-Juan; Yao, Zhong; Tang, Mei-Hua; Wei, Pin. Analysis of  -D-glutamyl-L-tryptophan in enzymatic synthesis procedure by high performance liquid chromatography. Fenxi Huaxue (2009), 37(10), 1528-1530. CODEN: FHHHDT ISSN:0253-3820. CAN 152:486059 AN 2009:1424015

5. Silin, Dmytro S.; Lyubomska, Oksana V.; Ershov, Feliks I.; Frolov, Valeriy M.; Kutsyna, Galyna A. Synthetic and natural immunomodulators acting as interferon inducers. Current Pharmaceutical Design (2009), 15(11), 1238-1247. CODEN: CPDEFP ISSN:1381-6128. CAN 150:396166 AN 2009:461115

6. Tuthill, Cynthia W. Immunomodulator compounds for the treatment of lung cancer. PCT Int. Appl. (2009), 97pp. CODEN: PIXXD2 WO 2009025830 A1 20090226 CAN 150:229680 AN 2009:237937

7. Kolobov, Alexandr A.; Simbirtsev, Andrey S. Treatment of allergic disease with immunomodulator compounds. PCT Int. Appl. (2008), 47pp. CODEN: PIXXD2 WO 2008143824 A1 20081127 CAN 149:570720 AN 2008:1448400

8. Rose, William A.; Tuthill, Cynthia; Pyles, Richard B. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2). International Journal of Antimicrobial Agents (2008), 32(3), 262-266. CODEN: IAAGEA ISSN:0924-8579. CAN 149:346806 AN 2008:1028482

9. Rios, Israel; Tuthill, Cynthia. Immunomodulator for treating or preventing mucosa diseases in radiation induced hamster model. PCT Int. Appl. (2008), 70pp. CODEN: PIXXD2 WO 2008100458 A2 20080821 CAN 149:259474 AN 2008:1009777

10. Wang, Qian; Yao, Zhong; Xun, Zhi-jin; Xu, Xiao-ying; Xu, Hong; Wei, Ping. Properties and catalytic mechanism of  -glutamyltranspeptidase from B. subtilis NX-2. Gaoxiao Huaxue Gongcheng Xuebao (2008), 22(2), 288-293. CODEN: GHGXEG ISSN:1003-9015. CAN 150:185279 AN 2008:579366

11. Johansen, Lisa M.; Owens, Christopher M.; Mawhinney, Christina; Chappell, Todd W.; Brown, Alexander T.; Frank, Michael G.; Altmeyer, Ralf. Compositions and methods for treatment of viral diseases. PCT Int. Appl. (2008), 237pp. CODEN: PIXXD2 WO 2008033466 A2 20080320 CAN 148:394354 AN 2008:352859

12. Wang, Qian; Yao, Zhong; Wu, Minggang; Xun, Zhijin; Zhou, Zhi; Xu, Hong; Wei, Ping. Kinetic model of enzymatic synthesis of  -D-glutamyl-L-tryptophan. Huagong Xuebao (Chinese Edition) (2008), 59(2), 431-436. CODEN: HUKHAI ISSN:0438-1157. CAN 148:401424 AN 2008:171837

13. Tuthill, Cynthia W.; Rudolph, Alfred R. Immunomodulators for the treatment of melanoma. PCT Int. Appl. (2007), 36 pp. CODEN: PIXXD2 WO 2007123847 A2 20071101 CAN 147:462257 AN 2007:1237472

14. Tuthill, Cynthia W.; Rudolph, Alfred R. Immunomodulator compounds as vaccine enhancers. PCT Int. Appl. (2006), 52pp. CODEN: PIXXD2 WO 2006116053 A1 20061102 CAN 145:469938 AN 2006:1153716

15. Tuthill, Cynthia W.; Rudolph, Alfred R. Treatment or prevention of genital viral infections with immunomodulator compounds. PCT Int. Appl. (2006), 16 pp. CODEN: PIXXD2 WO 2006076169 A2 20060720 CAN 145:117367 AN 2006:710748

16. Mossel, Eric C.; Tuthill, Cynthia W.; Rudolph, Alfred R. Treatment or prevention of hemorrhagic viral infections with peptidic immunomodulator compounds. PCT Int. Appl. (2006), 16 pp. CODEN: PIXXD2 WO 2006047702 A2 20060504 CAN 144:425658 AN 2006:411983

17. Aspinall, Richard J.; Pockros, Paul J. SCV-07(SciClone Pharmaceuticals/Verta). Current Opinion in Investigational Drugs (Thomson Scientific) (2006), 7(2), 180-185. CODEN: COIDAZ ISSN:1472-4472. CAN 145:179912 AN 2006:211289

18. Tuthill, Cynthia W.; Rudolph, Alfred R.; Kolobov, Alexander A.; Simbirtsev, Andrey S.; Petrov, Aleksandr V. Treatment or prevention of respiratory viral infections with immunomodulator compounds. PCT Int. Appl. (2005), 12 pp. CODEN: PIXXD2 WO 2005112639 A2 20051201 CAN 143:472545 AN 2005:1260987

19. Suzuki, Hideyuki; Kato, Kenji; Kumagai, Hidehiko. Development of an efficient enzymatic production of  -D-glutamyl-L-tryptophan (SCV-07), a prospective medicine for tuberculosis, with bacterial  -glutamyltranspeptidase. Journal of Biotechnology (2004), 111(3), 291-295. CODEN: JBITD4 ISSN:0168-1656. CAN 141:294728 AN 2004:557823

20. Kolobov, Alexander A.; Simbirtsev, Andrey S.; Pigareva, Natalia V.; Zabolotnych, Natalia V.; Vinogradova, Tat'yana I.; Kotov, Alexander Y.; Tuthill, Cynthia; Rudolph, Alfred R. Biological activity of the immunomodulatory peptide SCV-07 against murine tuberculosis. Peptides 2002, Proceedings of the European Peptide Symposium, 27th, Sorrento, Italy, Aug. 31-Sept. 6, 2002 (2002), 536-537. CODEN: 69EYXG CAN 141:81715 AN 2004:28554

21. Kolobov, Alexander; Simbirtsev, Andrey; Pigareva, Natalia; Kolodkin, Nikolay; Rudolph, Alfred; Tuthill, Cynthia. Further investigation of immunomodulatory properties of gamma-glutamyl containing peptides. Peptides 2000, Proceedings of the European Peptide Symposium, 26th, Montpellier, France, Sept. 10-15, 2000 (2001), Meeting Date 2000, 877-878. CODEN: 69EDWK CAN 139:83623 AN 2003:509794

22. Simbirtsev, Andrey; Kolobov, Alexander; Zabolotnych, Natalia; Pigareva, Natalia; Konusova, Valentina; Kotov, Alexander; Variouchina, Elena; Bokovanov, Vladimir; Vinogradova, Tatyana; Vasilieva, Svetlana; Tuthill, Cynthia. Biological activity of peptide SCV-07 against murine tuberculosis. Russian Journal of Immunology (2003), 8(1), 11-22. CODEN: RJIUAC ISSN:1028-7221. CAN 140:9493 AN 2003:497353

23. Kolobov, Alexander A.; Simbirtsev, Andrey S.; Kolodkin, Nikolay I.; Pigareva, Natalia V.; Rudolph, Alfred R.; Tuthill, Cynthia. Immunomodulatory properties of gamma-glutamyl and beta-aspartyl containing peptides. Peptides 1998, Proceedings of the European Peptide Symposium, 25th, Budapest, Aug. 30-Sept. 4, 1998 (1999), Meeting Date 1998, 526-527. CODEN: 68WKAY CAN 133:348860 AN 2000:288600

24. Bayes M; Rabasseda X; Prous J R Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology (2003), 25(5), 387-408. Journal code: 7909595. ISSN:0379-0355. PubMed ID 12851663 AN 2003321640

25. May Thomas S Cold war adversaries team up to conquer TB. Drug discovery today (2002), 7(23), 1149-50. Journal code: 9604391. ISSN:1359-6446. PubMed ID 12547010 AN 2003039725

26. Orellana Claudia Immune system stimulator shows promise against tuberculosis. The Lancet infectious diseases (2002), 2(12), 711. Journal code: 101130150. ISSN:1473-3099. PubMed ID 12467673 AN 2002706831

 

 

 

 

Contact MedKoo:

Email: sales@medkoo.com

 

(Keyword; CAS#; MedKoo code#)

 

 

 

 

 

 

 

About us  |  Services  |  Products  |  News  |  Careers  |  Contact us

© MedKoo Biosciences. All Rights Reserved

 link web design page